Search
forResearch 10 of 1000+
- Abemaciclib-Associated Skin, Hair, and Nail Toxicities: A Case Report
- Prophylaxis and Management of Skin Toxicities
- Cutaneous toxicities of cancer therapy
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Dermatological adverse events with taxane chemotherapy
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
Community 1 of 6
All community results →Learn
— no results
Try a deeper search in learn →